Edinburgh Research Explorer

Haemoglobin-based blood substitutes and sepsis

Research output: Contribution to journalArticle

Related Edinburgh Organisations

Open Access permissions

Open

Original languageEnglish
Pages (from-to)158-60
Number of pages3
JournalThe Lancet
Volume345
Issue number8943
DOIs
Publication statusPublished - 21 Jan 1995

Abstract

An important concern that has received little attention is the possible increased susceptibility to bacterial infections of patients infused with cell-free haemoglobin-based blood substitutes. We show that pyridoxalated polymerised human haemoglobin promotes fulminating Escherichia coli septicaemia in mice, which draws attention to the potential danger of such products in the clinic.

    Research areas

  • Animals, Blood Substitutes/pharmacology, Disease Susceptibility, Escherichia coli/pathogenicity, Escherichia coli Infections/microbiology, Hemoglobins/pharmacology, Mice, Pyridoxal Phosphate/analogs & derivatives, Sepsis/microbiology

ID: 80509240